AIDS 2022

 

The 24th International AIDS Conference (AIDS 2022) takes place from 29 July to 2 August in Montreal and virtually. HPTN researchers will present 13 abstracts (two oral; 11 posters) covering HPTN 068, HPTN 071, HPTN 082, HPTN 083, HPTN 084, HVTN 127/HPTN 087, HVTN 130/HPTN 089, HVTN 805/HPTN 093, and the HPTN Modelling Centre. In addition, a satellite session will focus on HPTN 071, and a special Global Village session will include a focus on HPTN 094. Presentations and posters will be uploaded when permitted.

Global Village Session

Date Study Program Number/Title Presenter(s) Details
Sunday, 30 July  HPTN 094 GVSY06/Beyond Addictophobia: Addressing Injection Risks and Drug-Linked Sexual Behaviours in HIV Prevention Science and Care Presenters: Russell Campbell, Wafaa El-Sadr, Steve Shoptaw, Alex Dubov

Global Village Session Presentation with Q&A

1:15 p.m. (ET)

Global Village Channel/Room 2

 

Satellite Session

Date Study Program Number/Title Presenter(s) Details
Tuesday, 2 August  HPTN 071

SA105/HPTN 071 (PopART): Where are We, What Have We Learnt and What is the Way Forward for HIV, TB and UTT?

Presenters: Helen Ayles, Sarah Fidler, Richard Hayes, Christophe Fraser

 

Panelists: Rachel Baggaley, Siobhan Crowley, Helen Ayles, Hanna Box, Bactrin Killingo, David Cieslewicz, David Serwadda

Satellite Session

 

8 a.m. (ET)

Room 510

Channel 8

Oral Presentations

Date Study Program Number/Title Presenter(s) Details
Friday, 29 July  HPTN 084

OALBX0107/Long-Acting Cabotegravir: Updated Efficacy and Safety Results from HPTN 084

Sinead Delany-Moretlwe

Oral Abstract

 

11:45 a.m. (ET)

Room 220

Channel 1
Monday, 1 August  HPTN 083/HPTN 084

OAEO304/The Relative Cost-Effectiveness of Long-Acting Injectable Cabotegravir Versus Oral Pre-Exposure Prophylaxis: A Modelled Economic Evaluation and Threshold Analysis in South Africa Based on the HPTN 083 and 084 Trials

Gesine Meyer-Rath

Oral Abstract

 

2:15 p.m. (EDT)

Room 516

Channel 6

Poster Exhibitions

Study Program Number/Title Presenter(s) Details
HPTN 071

PEMOC36/The Effect of Universal Testing and Treatment for HIV on Health-Related Quality of Life Data from the HPTN 071 (PopART) Cluster Randomised Trial in Zambia and South Africa

 Katherine Davis Poster Exhibition
HVTN 127/HPTN 087 and HVTN 130/HPTN 089

PESUA14/Administration of the Broadly Neutralizing, CD4-Binding Site Targeting Antibody VRC07-523LS in Dual- and Triple-Antibody Combinations with 10-1074, PGT121 and/or PGDM1400: Impact on Pharmacokinetics Compared to VRC07-523LS Administration Alone

 Stephen Walsh Poster Exhibition

E-Posters

Study Program Number/Title Presenter(s) Details
HPTN 068

EPD151/Trajectories of Depressive Symptoms and HIV-Related Sexual Behaviors Among Adolescent Girls and Young Women in Rural South Africa (HPTN 068)

 Nivedita Bhushan E-Poster
HPTN 068

EPD158/Effects of Quality of Caregiver-Adolescent Relationship on HIV, HSV-2 and on Pregnancy Incidence Among Young Women in Rural South Africa Enrolled in HPTN 068

 Nosipho Shangase E-Poster
HPTN 071 EPD028/Mobility and HIV Transmission Across Three Urban Communities in Zambia: Using Qualitative Data to Interpret Phylogenetics in a Mixed Methods Analysis of HPTN 071 (PopART) Data Melvin Simuyaba E-Poster
HPTN 071 EPD387/Associations between HIV-related stigma and health-related quality of life among people living with HIV in Zambia and South Africa: cross-sectional analysis of data from the HPTN071 (PopART) study Emily Hall E-Poster
HPTN 082

EPD339/Motivations for Starting, Stopping and Restarting Oral PrEP: Experiences of Adolescent Girls and Young Women in the HPTN 082 Trial

 Lisa Mills E-Poster
HPTN 083

EPLBC04/Transgender Women (TGW) in HPTN 083: An Evaluation of Safety, Efficacy, and Gender Affirming Hormonal Therapy (GAHT) Interactions with Long-acting Cabotegravir (CAB-LA)

Beatriz Grinsztejn

 E-Poster
HPTN 084

EPD103/Acceptability of Injectable Cabotegravir Versus Daily Oral TDF/FTC for PrEP: Lesson from HPTN 084

 Nomhle Khoza E-Poster
HVTN 805/HPTN 093 EPLBB08/Analytical Treatment Interruption (ATI) Among African Women with Early ART Initiation with or without VRC01 Circulating at HIV Acquisition: Study Design and Early Observations of Viral Rebound and Control 

Shelly Karuna

 E-Poster

HPTN Modelling Centre

EPC150/Population-Level Impact of Expanding PrEP Coverage Among Men Who Have Sex with Men with Long-Acting Injectable Cabotegravir: Model Comparison Analysis for Atlanta, U.S. and Montreal, Canada

 Sarah Stansfield E-Poster